Via the expression of PD-L1, cancer-associated fibroblasts have a major immunosuppressive action on tumor cells [81] but the immunosuppression can be lifted or reduced by targeting PD-L1 directly or indirectly via TGF-β, for example. This evidence concerns the gene CD274 and neoplasm.